SUBSTANCE ABUSE COUNSELING SERVICES

Brand Owner (click to sort) Address Description
CHOCTAW NATION RECOVERY CENTER Choctaw Nation of Oklahoma 1802 Chukka Hina Drive Durant OK 74701 Substance abuse counseling services;RECOVERY CENTER;
FOR REAL HELP, RIGHT NOW GEORGE S. GLASS, M.D., P.A. SUITE 225 2616 SOUTH LOOP WEST HOUSTON TX 77054 substance abuse counseling services;
IT'S NOT YOUR FAULT, BUT IT IS YOUR PROBLEM GEORGE S. GLASS, M.D., P.A. SUITE 225 2616 SOUTH LOOP WEST HOUSTON TX 77054 substance abuse counseling services;
SACS Kapalcik, Michele 4595 NW 48th Lane Ocala FL 34482 SUBSTANCE ABUSE COUNSELING SERVICES;Substance Abuse Counseling Services, Mental Health Counseling Services, Psychological Services;
WITH SOBRIETY, ANYTHING IS POSSIBLE RACING FOR RECOVERY 6202 Trust Dr. Holland OH 43528 Substance abuse counseling services, namely, providing assistance in overcoming alcohol or drug addiction; Providing a website featuring information about addiction, namely, in the field of overcoming alcohol or drug addiction; Providing wellness services, namely, personal assessments, substance-abuse interventions, and support groups in the field of substance-abuse;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The present invention describes compounds, compositions and methods of using the same comprising lysine covalently attached to amphetamine. These compounds and compositions are useful for reducing or preventing abuse and overdose of amphetamine. These compounds and compositions find particular use in providing an abuse-resistant alternative treatment for certain disorders, such as attention deficit hyperactivity disorder (ADHD), ADD, narcolepsy, and obesity. Oral bioavailability of amphetamine is maintained at therapeutically useful doses. At higher doses bioavailability is substantially reduced, thereby providing a method of reducing oral abuse liability. Further, compounds and compositions of the invention decrease the bioavailability of amphetamine by parenteral routes, such as intravenous or intranasal administration, further limiting their abuse liability.